arrow
R

Richard B. Lock

UNSW
H指数:66
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
2025-11-010
OA
Polyamine depletion limits progression of acute leukaemia
2025-02-220
PRE
Lessons learned from 20 years of preclinical testing in pediatric cancers

从20年的儿科癌症临床前测试中吸取的经验教训

2024-12-010
PRE
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia
2024-11-080
OAAI
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
2024-11-060
OAAI
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
2024-08-280
OAAI
PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
2024-06-180
OAAI
Precision-guided treatment in high-risk pediatric cancers
2024-06-067
OAAI
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

原发性肿瘤细胞的高通量药物筛选确定治疗高危癌症儿童的治疗策略

2023-07-3114
OAAI
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
2023-05-179
PRE